The effect of regulation of high blood pressure on plasma endothelin-1 levels in blacks with hypertension

American Journal of Hypertension

Volumn 11, Issue 11 I, 1998, Pages 1381-1385

  Ergul, Sitki ^a   Ergul, Adviye ^b   Hudson, John A ^a   Puett, David ^b   Wieman, Bobbye M ^a   Durham, Marcus D ^a   Parish, David C ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Georgia ^*  (United States)

Author keywords

Antihypertensive treatment; Endothelin receptor antagonists; Endothelin 1; Essential hypertension; Race

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; NEGRO; PRIORITY JOURNAL; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0031739230     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00150-2     Document Type: Article

References (15)

1. Vanhoutte P.M., Luscher T.F. Peripheral mechanisms in cardiovascular regulation Transmitters, receptors and the endothelium . Terazi R.C., Zanchetti A. Handbook of Hypertension. 1986;96-123 Elsevier, Amsterdam.
2. Gillum R.F. Pathophysiology of hypertension in blacks and whites. Hypertension. 1:1979;468-475.
3. AHA Special Report cardiovascular diseases and stroke in African-Americans and other racial minorities in the United States . Circulation. 83:1991;1462-1480.
4. Ergul S., Parish D.C., Puett D., Ergul A. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension. 8:1996;652-655.
5. Rubanyi G.M., Polokoff M.A. Endothelins molecular biology, biochemistry, pharmacology, physiology, and pathophysiology . Pharmacol Rev. 46:1994;325-415.
6. Webb M.L., Meek T.D. Inhibitors of endothelin. Med Res Rev. 7:1997;17-67.
7. Haak T., Jungmann E., Felber A., et al. Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens. 5:1992;161-166.
8. Schiffrin E.L., Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens. 4:1991;303-308.
9. Shichiri M., Hirata Y., Ando K., et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 15:1990;493-496.
10. Kohno M., Yasunari K., Murakawa K., et al. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 88:1990;614-618.
11. Evans R.R., Phillips B.G., Singh G., et al. Racial and gender differences in endothelin-1. Am J Cardiol. 78:1996;486-488.
12. Fang J., Madhavan S., Alderman M.H. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med. 335:1996;1545-1551.
13. Cooper R., Rotimi C., Ataman S., et al. The prevalence of hypertension in seven populations of West African origin. Am J Pub Health. 87:1997;160-168.
14. Fray J.C.S. Hypertension in blacks physiological, psy-chosocial, theoretical, and therapeutic challenges . Fray J.C.S., Douglas J.G. Pathophysiology of Hyper-tension in Blacks. 1993;3-22 Oxford University Press, New York.
15. Anderson N.B., McNeilly M. Autonomic reactivity and hypertension in blacks towards a contextual model . Fray J.C.S., Douglas J.G. Pathophysiology of Hypertension in Blacks. 1993;107-139 Oxford University Press, New York.